PHINIA Q1 Sales Rise 10.3%, but FCF Conversion Remains Key Test

What happened

PHINIA reported Q1 2026 net sales of $878 million, a 10.3% increase year-over-year, aided by the SEM acquisition and favorable foreign exchange. However, organic growth was modest, with sales excluding FX and M&A up only about $39 million. The company highlighted strategic wins in alternative fuels and end-market diversification, but the investment thesis hinges on whether this revenue growth translates into adjusted free cash flow within the guided $200–$240 million range for 2026. The Q1 result is a positive data point but does not materially alter the outlook, as capital returns remain discretionary and dependent on cash generation. Investors should focus on FCF conversion and repurchase activity in upcoming quarters to validate the shareholder-return narrative.

Implication

The base case scenario (55% probability, $68 value) remains intact, but the stock's current price leaves little margin of safety. A better entry point is near $58, where risk/reward improves. Watch for sustained repurchases and FCF guidance reaffirmation in Q2.

Thesis delta

The Q1 print is consistent with the base case scenario in the DeepValue report (55% probability, $68 value). There is no material shift in the investment thesis; the focus remains on FCF conversion and capital return execution. The company's strategic wins in diversification are supportive but not yet reflected in near-term earnings.